Literature DB >> 15696103

Role of IL-10 deficiency in excessive nuclear factor-kappaB activation and lung inflammation in cystic fibrosis transmembrane conductance regulator knockout mice.

Aicha Saadane1, Jindrich Soltys, Melvin Berger.   

Abstract

BACKGROUND: Patients with cystic fibrosis (CF) and CF transmembrane conductance regulator knockout (CF-KO) mice are deficient in pulmonary IL-10 and have excessive inflammatory response to Pseudomonas aeruginosa infection.
OBJECTIVE: We hypothesized that local IL-10 deficiency in the lung was responsible for prolonged and excessive inflammatory responses and observations of inflammation in the absence of infection.
METHODS: To determine whether IL-10 deficiency could account for persistent inflammation in CF mice independent of interactions of bacteria with epithelial cells, we challenged IL-10-knockout (IL-10-KO), CF-KO, and wild-type (WT) mice intratracheally with LPS and determined the effects of IL-10 replacement in CF-KO mice.
RESULTS: In response to LPS, IL-10-KO and CF-KO mice had more neutrophils and proinflammatory cytokines in bronchoalveolar lavage than WT mice. Both types of knockout mice had more profound and prolonged consumption of I-kappaB and increased activation of nuclear factor kappaB (NF-kappaB). Activated NF-kappaB persisted for 6 to 8 hours in CF-KO and IL-10-KO mice but was not detected beyond 2 hours in WT mice. IL-10 treatment of CF-KO mice attenuated the reduction in I-kappaBalpha and activation of NF-kappaB and reduced the excessive inflammation.
CONCLUSION: Similarities in the responses of CF-KO and IL-10-KO mice and correction of excessive responses in CF mice by exogenous IL-10 suggest that deficiency of IL-10 may be responsible for prolonged and excessive inflammatory responses in CF. Because LPS was used as the stimulus, these excessive responses are independent of any possible differences in the interactions of bacteria with CF epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15696103     DOI: 10.1016/j.jaci.2004.10.044

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  19 in total

Review 1.  MUC1 mucin: a peacemaker in the lung.

Authors:  K Chul Kim; Erik P Lillehoj
Journal:  Am J Respir Cell Mol Biol       Date:  2008-07-10       Impact factor: 6.914

2.  Parthenolide inhibits IkappaB kinase, NF-kappaB activation, and inflammatory response in cystic fibrosis cells and mice.

Authors:  Aicha Saadane; Sophia Masters; Joseph DiDonato; Jingfeng Li; Melvin Berger
Journal:  Am J Respir Cell Mol Biol       Date:  2007-02-01       Impact factor: 6.914

3.  Differing effects of clarithromycin and azithromycin on cytokine production by murine dendritic cells.

Authors:  K Sugiyama; R Shirai; H Mukae; H Ishimoto; T Nagata; N Sakamoto; H Ishii; S Nakayama; K Yanagihara; Y Mizuta; S Kohno
Journal:  Clin Exp Immunol       Date:  2007-03       Impact factor: 4.330

4.  Peroxiredoxin 6 fails to limit phospholipid peroxidation in lung from Cftr-knockout mice subjected to oxidative challenge.

Authors:  Stéphanie Trudel; Mairead Kelly; Janine Fritsch; Thao Nguyen-Khoa; Patrice Thérond; Martine Couturier; Michal Dadlez; Janusz Debski; Lhousseine Touqui; Benoit Vallée; Mario Ollero; Aleksander Edelman; Franck Brouillard
Journal:  PLoS One       Date:  2009-06-29       Impact factor: 3.240

5.  Reduced caveolin-1 promotes hyperinflammation due to abnormal heme oxygenase-1 localization in lipopolysaccharide-challenged macrophages with dysfunctional cystic fibrosis transmembrane conductance regulator.

Authors:  Ping-Xia Zhang; Thomas S Murray; Valeria R Villella; Eleonora Ferrari; Speranza Esposito; Anthony D'Souza; Valeria Raia; Luigi Maiuri; Diane S Krause; Marie E Egan; Emanuela M Bruscia
Journal:  J Immunol       Date:  2013-04-19       Impact factor: 5.422

Review 6.  Chronic inflammation in the cystic fibrosis lung: alterations in inter- and intracellular signaling.

Authors:  David Nichols; James Chmiel; Melvin Berger
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

7.  Cystic fibrosis transmembrane conductance regulator controls lung proteasomal degradation and nuclear factor-kappaB activity in conditions of oxidative stress.

Authors:  Emilie Boncoeur; Telma Roque; Elise Bonvin; Vinciane Saint-Criq; Monique Bonora; Annick Clement; Olivier Tabary; Alexandra Henrion-Caude; Jacky Jacquot
Journal:  Am J Pathol       Date:  2008-03-27       Impact factor: 4.307

8.  Protective role of interleukin-10 in ozone-induced pulmonary inflammation.

Authors:  Gillian S Backus; Reuben Howden; Jennifer Fostel; Alison K Bauer; Hye-Youn Cho; Jacqui Marzec; David B Peden; Steven R Kleeberger
Journal:  Environ Health Perspect       Date:  2010-09-08       Impact factor: 9.031

9.  Parthenolide inhibits ERK and AP-1 which are dysregulated and contribute to excessive IL-8 expression and secretion in cystic fibrosis cells.

Authors:  Melvin Berger; Tracey L Bonfield; Aicha Saadane; Jean Eastman
Journal:  J Inflamm (Lond)       Date:  2011-10-12       Impact factor: 4.981

10.  Reduced IL-10 production in fetal type II epithelial cells exposed to mechanical stretch is mediated via activation of IL-6-SOCS3 signaling pathway.

Authors:  Michael A Hokenson; Yulian Wang; Renda L Hawwa; Zheping Huang; Surendra Sharma; Juan Sanchez-Esteban
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.